Trial · NCT00563368
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Weight Loss From Baseline to Week 28 | Placebo | 1.7 | Standard Error 0.61 | percent weight loss | |
| Percent Weight Loss From Baseline to Week 28 | PHEN 7.5 mg | 5.5 | Standard Error 0.61 | percent weight loss | |
| Percent Weight Loss From Baseline to Week 28 | TPM 46 mg | 5.1 | Standard Error 0.61 | percent weight loss | |
| Percent Weight Loss From Baseline to Week 28 | VI-0521 Mid | 8.5 | Standard Error 0.62 | percent weight loss | |
| Percent Weight Loss From Baseline to Week 28 | PHEN 15 mg | 6.1 | Standard Error 0.61 | percent weight loss | |
| Percent Weight Loss From Baseline to Week 28 | TPM 92 mg | 6.4 | Standard Error 0.62 | percent weight loss | |
| Percent Weight Loss From Baseline to Week 28 | VI-0521 Top | 9.2 | Standard Error 0.61 | percent weight loss | |
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | Placebo | 15.5 | percentage of participants | ||
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | PHEN 7.5 mg | 43.3 | percentage of participants | ||
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | TPM 46 mg | 39.2 | percentage of participants | ||
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | VI-0521 Mid | 62.1 | percentage of participants | ||
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | PHEN 15 mg | 46.2 | percentage of participants | ||
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | TPM 92 mg | 48.6 | percentage of participants | ||
| Percentage of Subjects With at Least 5% Weight Loss at Week 28 With LOCF | VI-0521 Top | 66.0 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00563368/results